Gou Watanabe1, M Itoh2, X Duan2, H Watabe3, N Mori4, H Tada5, A Suzuki6, M Miyashita5, N Ohuchi5, T Ishida5. 1. Division of Surgical Oncology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. wago@med.tohoku.ac.jp. 2. Sendai Medical Imaging Center, Sendai, 980-0022, Japan. 3. Cyclotron and Radioisotope Center, Tohoku University, Sendai, 980-0824, Japan. 4. Division of Diagnostic Radiology, Tohoku University School of Medicine, Sendai, 980-8575, Japan. 5. Division of Surgical Oncology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. 6. Department of Breast and Endocrine Surgery, Tohoku Medical and Pharmaceutical University, Sendai, 983-8512, Japan.
Abstract
OBJECTIVES: We aimed to determine whether high-resolution specimen-positron emission mammography (PEM) using fluorodeoxyglucose (18F-FDG) can reveal extension of breast cancer in breast-conserving surgery (BCS), and assess the safety of radiation exposure to medical staff. METHODS: Sixteen patients underwent positron emission tomography, and then BCS with intraoperative frozen section analysis on the same day. Resected specimens with remaining 18F-FDG accumulation were scanned by high-resolution PEM. At least 1 day after surgery, tumour extension was evaluated by three independent experienced readers and by binarized images from the specimen-PEM data. Intraoperative exposure of medical staff to 18F-FDG was measured. RESULTS: Specimen-PEM evaluations of binarized images and the three investigators detected all (100 %, 12/12) invasive lesions and 94.4 % (17/18) of in situ lesions using both methods. The positive predictive value of the accumulated lesions was 74.4 % (29/39) for the binarized images and 82.9 % (29/35) for the three investigators. Analysis of intraoperative frozen sections detected 100 % (2/2) of the margin-positive cases, also detected by both specimen-PEM evaluation methods with no false-positive margin cases. The mean exposure of the medical staff to 18F was 18 μSv. CONCLUSIONS: Specimen-PEM detected invasive and in situ lesions with high accuracy and allowable radiation exposure. KEY POINTS: • Specimen-PEM detected invasive and in situ lesions with high accuracy. • Specimen-PEM predicted complete resection with the same accuracy as frozen section analysis. • Breast-conserving surgery after fluorodeoxyglucose injection was performed with low medical staff exposure.
OBJECTIVES: We aimed to determine whether high-resolution specimen-positron emission mammography (PEM) using fluorodeoxyglucose (18F-FDG) can reveal extension of breast cancer in breast-conserving surgery (BCS), and assess the safety of radiation exposure to medical staff. METHODS: Sixteen patients underwent positron emission tomography, and then BCS with intraoperative frozen section analysis on the same day. Resected specimens with remaining 18F-FDG accumulation were scanned by high-resolution PEM. At least 1 day after surgery, tumour extension was evaluated by three independent experienced readers and by binarized images from the specimen-PEM data. Intraoperative exposure of medical staff to 18F-FDG was measured. RESULTS: Specimen-PEM evaluations of binarized images and the three investigators detected all (100 %, 12/12) invasive lesions and 94.4 % (17/18) of in situ lesions using both methods. The positive predictive value of the accumulated lesions was 74.4 % (29/39) for the binarized images and 82.9 % (29/35) for the three investigators. Analysis of intraoperative frozen sections detected 100 % (2/2) of the margin-positive cases, also detected by both specimen-PEM evaluation methods with no false-positive margin cases. The mean exposure of the medical staff to 18F was 18 μSv. CONCLUSIONS: Specimen-PEM detected invasive and in situ lesions with high accuracy and allowable radiation exposure. KEY POINTS: • Specimen-PEM detected invasive and in situ lesions with high accuracy. • Specimen-PEM predicted complete resection with the same accuracy as frozen section analysis. • Breast-conserving surgery after fluorodeoxyglucose injection was performed with low medical staff exposure.
Authors: Lee G Wilke; Tomasz Czechura; Chih Wang; Brittany Lapin; Erik Liederbach; David P Winchester; Katharine Yao Journal: JAMA Surg Date: 2014-12 Impact factor: 14.766
Authors: Wendie A Berg; Kathleen S Madsen; Kathy Schilling; Marie Tartar; Etta D Pisano; Linda Hovanessian Larsen; Deepa Narayanan; Al Ozonoff; Joel P Miller; Judith E Kalinyak Journal: Radiology Date: 2010-11-12 Impact factor: 11.105
Authors: G Ciccarelli; M R Di Virgilio; S Menna; L Garretti; A Ala; R Giani; R Bussone; G Canavese; E Berardengo Journal: Radiol Med Date: 2007-04-20 Impact factor: 3.469
Authors: O Riedl; F Fitzal; N Mader; P Dubsky; M Rudas; M Mittlboeck; M Gnant; R Jakesz Journal: Eur J Surg Oncol Date: 2008-08-15 Impact factor: 4.424
Authors: Tehillah S Menes; Paul Ian Tartter; Ira Bleiweiss; James H Godbold; Alison Estabrook; Sharon Rosenbaum Smith Journal: Ann Surg Oncol Date: 2005-10-03 Impact factor: 5.344
Authors: Neslihan Cabioglu; Kelly K Hunt; Aysegul A Sahin; Henry M Kuerer; Gildy V Babiera; S Eva Singletary; Gary J Whitman; Merrick I Ross; Frederick C Ames; Barry W Feig; Thomas A Buchholz; Funda Meric-Bernstam Journal: Ann Surg Oncol Date: 2007-01-28 Impact factor: 5.344
Authors: Eva C Gombos; Jagadeesan Jayender; Danielle M Richman; Diana L Caragacianu; Melissa A Mallory; Ferenc A Jolesz; Mehra Golshan Journal: Radiology Date: 2016-06-22 Impact factor: 11.105